The Vdr: Why Your Vitamin D3 Might Not Be Protecting Your Ageing Brain
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
We write a new article on supplements every day , all detailed, with citations.
Once a week we send an email containing a list of the last 7 days articles. Please sign up and also feel free to share the articles with friends and family who you think might benefit.
Simon Parrott – Vitacuity Ltd
Depression and dementia are biologically linked through three main pathways: chronic inflammation in the brain, a dysregulated stress response system that keeps stress hormone levels too high, and reduced brain plasticity (the brain’s ability to form new connections and repair itself). The relationship works both ways, with depression increasing dementia risk and early cognitive changes worsening depression. Recent research shows that repeated episodes of depression, worsening symptoms over time, and active depression within the past two years all significantly raise the risk of cognitive decline and Alzheimer’s disease.
Key findings reveal that even mild, persistent depressive symptoms that you’ve learned to live with can cause damage over years. One large study found that cognitive decline actually starts before depression becomes obvious, creating a self-reinforcing downward spiral. Between 20 and 50 percent of older adults with depression also meet criteria for mild cognitive impairment. Interestingly, the depression-dementia link appears stronger in men with existing cognitive impairment than in women, suggesting prevention strategies may need to differ by sex.
Physical aerobic exercise shows the strongest evidence as a protective intervention, directly counteracting the biological mechanisms that link depression to dementia. Non-pharmacological approaches like regular exercise, cognitive engagement, and quality sleep are recommended as first-line treatment. The evidence for antidepressant medications as brain protection is mixed and requires personalised assessment. One high-quality study found no increased dementia risk from depression, reminding us the relationship is complex and not universal across all populations.
Verdict: Depression is a modifiable brain health risk factor that deserves serious, proactive treatment and monitoring, particularly with regular aerobic exercise as a core intervention.
What if the low mood you’ve been managing for the past few years wasn’t just affecting your quality of life today, but quietly reshaping your brain’s future? Most people think of depression and dementia as two separate concerns, one a mental health issue, the other a neurological one. But a growing and compelling body of research suggests they are deeply, biologically intertwined. Not just co-occurring by chance, but sharing the same destructive pathways through the brain. And here’s the part that changes everything: if depression is a modifiable risk factor for dementia, then treating it well, and treating it early, may be one of the most powerful things you can do for your long-term cognitive health. That reframe is worth sitting with.
To understand why depression and dementia are linked, you need to understand what depression actually does to the brain, because it does quite a lot.
Depression isn’t just a mood disorder. It’s a whole-body inflammatory event that affects brain structure, stress hormone systems, and the very machinery that keeps neurons healthy and connected. Three biological mechanisms appear to sit at the centre of the depression-dementia relationship [1][7]:
1. Neuroinflammation. Depression triggers chronic low-grade inflammation throughout the body, including in the brain. This inflammation damages neurons and disrupts the glial cells (the brain’s support and cleaning crew) that help clear toxic proteins. The same inflammatory environment is a hallmark of Alzheimer’s disease [2][8].
2. HPA axis dysfunction. The hypothalamic-pituitary-adrenal axis is your stress response system. In depression, this system becomes dysregulated, leading to chronically elevated cortisol, the stress hormone. Sustained high cortisol is directly toxic to the hippocampus, the brain region most critical for memory formation and one of the first areas damaged in Alzheimer’s [1][2][8].
3. Neuroplasticity deficits. Healthy brains constantly rewire themselves, forming new connections, even new neurons in key regions. Depression impairs this process, reducing BDNF (brain-derived neurotrophic factor), a protein sometimes called “fertiliser for the brain.” When neuroplasticity is suppressed, the brain loses its ability to repair and adapt [1][7].
These three mechanisms don’t just sit alongside Alzheimer’s disease, they *accelerate* it. And critically, the relationship appears to run in both directions: depression can hasten cognitive decline, and early cognitive decline can worsen depression [1][3]. This bidirectionality makes it harder to untangle cause and effect, but it doesn’t make the link any less real or actionable.
Evidence grade: Strong, large population cohorts and meta-analysis of 16 longitudinal studies
One of the most important recent advances in this research is the move away from asking “does depression cause dementia?” to asking “what *kind* of depression, and for how long?” The answer is striking.
A landmark study published in the *Journal of Affective Disorders* (2026) drew on two major cohorts: 97,157 participants from the UK Biobank (mean age 56.5, followed for 14 years) and 464 participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI, mean age 75.8, followed for 5 years) [4][15].
In the UK Biobank group, each additional period of depression was associated with a 28% increased risk of all-cause dementia (hazard ratio 1.28, 95% CI 1.07–1.53) and a 25% increased risk specifically of Alzheimer’s disease (HR 1.25, 95% CI 1.04–1.51) [4].
In the ADNI cohort, participants whose depressive symptoms were *mild but increasing*, not just consistently high, faced more than double the risk of developing Alzheimer’s (HR 2.33, 95% CI 1.33–4.82) compared to those with consistently absent symptoms [4][15].
The researchers then went further and meta-analysed 16 longitudinal cohort studies to identify the riskiest depression trajectories. Mid-to-late life depression carried the highest relative risk (RR = 1.84). Stable high symptoms came in close behind (RR = 1.74), followed by increasing symptoms (RR = 1.68). Even stable *mild* symptoms conferred a 43% elevated relative risk (RR = 1.43) [4][15].
The message is clear: it is not just severe or dramatic depression that raises your risk. Low-grade, smouldering depressive symptoms that you’ve learned to live with, the persistent flatness, the quiet withdrawal, the diminished enjoyment, may be doing slow but meaningful damage over time. This research strongly supports monitoring and managing depressive symptoms dynamically, not just at a single point in time.
Evidence grade: Strong, 40,167 participants across three international prospective cohorts
A major 2026 study published in *Archives of Gerontology and Geriatrics* analysed data from 40,167 older adults without baseline depression across three large international studies: CHARLS (China), HRS (USA), and SHARE (Europe), spanning 2010–2021 with 401,017.8 person-years of follow-up [5].
The finding was unsettling in its clarity: cognitive decline doesn’t just happen *after* depression. It starts *before* it. Participants who went on to develop depression were already showing faster cognitive decline across memory, executive function, and orientation *prior to* their depression onset. Then, at the point of depression onset, there was an acute drop in cognitive function. And after that, the decline accelerated further [5].
This means the relationship between depression and cognitive decline is not a simple arrow pointing in one direction. They appear to be caught in a mutually reinforcing spiral, each making the other worse. For people in the 40–65 age range, this has a practical implication: cognitive dips you might attribute to stress or age may sometimes signal an emerging depressive episode. And vice versa, a low mood that isn’t fully treated may be quietly eroding cognitive function even before it becomes clinically obvious.
Evidence grade: Promising, observational study, 2,655 participants, 41.8 months median follow-up
A study using the National Alzheimer’s Coordinating Center dataset followed 2,655 older adults with a history of depression and normal cognition at baseline, for a median of 41.8 months [9]. Of those, 22.1% developed either mild cognitive impairment (MCI) or dementia during the follow-up period.
After adjusting for multiple confounders, two depression-specific variables remained significantly and independently associated with MCI or dementia development: having active depression within the last two years (hazard ratio 1.41, 95% CI 1.15–1.74) and higher severity of depression (HR 1.05 per unit increase, 95% CI 1.02–1.09) [9].
Published in the *Journal of Clinical Psychiatry* (2018), this study matters because it demonstrates that *recency* and *severity* both matter, not just lifetime history of depression. It’s not enough to have “had depression once and got through it.” If your depression is currently active or has been in the past two years, your MCI risk is meaningfully elevated. This is a strong argument for treating depression thoroughly and continuously monitoring for cognitive changes in people with a depressive history.
Evidence grade: Promising, narrative review with convergent findings across multiple studies
A 2025 review published in *Focus* (American Psychiatric Association) highlighted that between 20% and 50% of people with late-life depression (LLD) meet diagnostic criteria for mild cognitive impairment [12]. That is a remarkable overlap.
The review identified a characteristic cognitive pattern in LLD: psychomotor slowing (thinking and moving more slowly than usual), variable attention, and executive dysfunction, the kind of impairment that affects planning, decision-making, and mental flexibility [12]. These are the functions that quietly erode independence and quality of life before anyone calls it dementia.
There is also a diagnostic challenge worth flagging. People with late-life depression tend to *emphasise* their memory problems, they’ll vividly describe specific moments of forgetting. People with early Alzheimer’s, by contrast, often minimise and conceal their cognitive difficulties, lacking insight into the decline. This means depression can sometimes masquerade as dementia or co-exist with it in ways that complicate both diagnosis and treatment [3][12].
The review’s practical conclusion: non-pharmacological interventions, aerobic exercise, cognitive remediation, and neuromodulation, are highly recommended as first-line approaches for LLD with cognitive symptoms, partly because antidepressants have weaker evidence specifically in people who already have cognitive deficits [12].
Evidence grade: Promising, 811 participants with MCI in the ADNI cohort, longitudinal
A 2025 study published in *Alzheimer’s & Dementia* examined sex-specific associations between depressive symptom trajectories and cognitive decline in 811 individuals with mild cognitive impairment from the ADNI cohort [11].
The results revealed a striking divergence. In men, increasing depressive symptoms were associated with significantly steeper rates of cognitive and functional decline, and with an increased risk of converting from MCI to full Alzheimer’s disease. In women, these associations were largely absent [11].
This doesn’t mean depression is harmless in women, it clearly isn’t, given the broader data above. But it does suggest that the *pathway* through which depression drives cognitive risk may differ by sex, and that prevention strategies may need to be tailored accordingly. The researchers noted that relying on single time-point depression assessments obscures these sex-specific patterns, which may be why earlier research produced inconsistent findings.
Evidence grade: Promising, mechanistic review with supporting human and animal evidence
Two 2025 reviews converge on a particularly important point: physical exercise doesn’t just improve mood. It directly targets the biological mechanisms that link depression to dementia [2][8].
A review published in the *Journal of Neurochemistry* (2025) identified the shared pathways between dementia and depression, HPA axis dysfunction, hippocampal and prefrontal cortex atrophy, neuroinflammation, and cognitive decline, and examined the evidence for physical exercise modulating each one [2][8].
The mechanisms are specific and important. Exercise reduces cortisol dysregulation, suppresses neuroinflammatory markers, stimulates BDNF production (supporting neuroplasticity), and appears to preserve hippocampal volume. The review also highlights what researchers call “muscle-brain crosstalk”, the idea that skeletal muscle, when active, releases signalling molecules (myokines) that have direct neuroprotective effects on the brain [2][8].
This is not a vague “exercise is good for you” observation. The research identifies specific pathways through which movement acts as a biological intervention at the intersection of depression and neurodegeneration. For people aged 40–65, this positions regular aerobic activity not as a lifestyle preference but as a genuine brain-preservation strategy.
Honesty matters here, and there are real gaps in this research that we should acknowledge clearly.
The direction of causality is still genuinely uncertain. We know depression and dementia co-occur and share biological pathways. We know depression predicts later dementia in longitudinal studies. But we cannot yet say with certainty whether depression *causes* dementia, whether early (subclinical) dementia *causes* depression, or whether both arise from a third common factor, perhaps genetic vulnerability or early-life brain insults. The bidirectional relationship makes this deeply difficult to untangle [1][3][7].
The Whitehall II study found no effect. It would be dishonest not to mention this. A well-designed 2023 study using the Whitehall II cohort, 1,063 individuals with depression followed for 15 years, found that depression in people over 50 was *not* associated with increased cognitive decline on episodic memory, verbal fluency, or abstract reasoning tests [14]. The authors did find that depressed individuals performed worse *at baseline* on several cognitive measures, but their *rate of decline* did not differ significantly. This is a meaningful finding from a credible long-term study. It doesn’t overturn the broader evidence, but it does remind us that the relationship is not uniformly observed across all populations and all study designs. Why the discrepancy? Possibly because the Whitehall II cohort skewed towards employed civil servants (healthier baseline than the general population), possibly because of how depression was defined, or possibly because the relationship genuinely varies by age of onset, severity, and recurrence patterns [14].
Antidepressants are not a clear answer. The research on antidepressants in dementia contexts is genuinely conflicted. Some studies suggest they may offer neuroprotective effects, reducing amyloid-beta accumulation, promoting neurogenesis, reducing neuroinflammation [6]. Others suggest antidepressant use in older adults with undiagnosed early-stage dementia may actually be associated with *increased* dementia risk [6]. Current guidelines broadly recommend non-pharmacological interventions as first-line treatment for depression in older adults with cognitive concerns [3][10][12]. This is an area that genuinely requires individualised clinical assessment, not a simple population-level recommendation.
Sex-specific pathways need more investigation. The finding that increasing depression raises dementia risk in men but not women with MCI [11] is intriguing but comes from a single cohort study of 811 people. We need much larger and more diverse studies before drawing firm sex-specific conclusions.
Racial and ethnic differences are understudied. A 2024 study found that higher depressive symptoms were associated with faster semantic memory decline specifically in Black and Latino participants, a pattern not observed with the same strength in Asian or White participants [13]. This raises important questions about whether the depression-cognition relationship differs meaningfully by population, and whether interventions need to be culturally and demographically tailored. The evidence base here is thin and more diverse research is urgently needed [13].
Let’s be the brilliant, practical friend here and cut through to what this actually means for someone in their 40s, 50s, or 60s who wants to protect their brain.
1. Take depression seriously as a brain health issue, not just a mood issue. The research is clear enough across large populations and long follow-ups that persistent, recurrent, or worsening depressive symptoms are meaningfully associated with elevated dementia risk. This doesn’t mean every bout of depression leads to dementia, of course it doesn’t. But it does mean that low mood is not something to just push through or quietly endure year after year. Treating depression well is, on the current evidence, also treating your future brain.
2. Recurrence and recency matter most. If you’ve had multiple episodes of depression, or if you’ve had active depression in the past two years, the research suggests you are in a higher-risk group for cognitive decline [4][9][15]. This is not a reason to panic, it is a reason to be proactive. Work with your GP or mental health professional on a management plan that doesn’t just treat the acute episode and then leave you to manage alone.
3. Move your body, this has the clearest mechanistic evidence of anything in this research. Aerobic exercise directly targets HPA axis dysfunction, reduces neuroinflammation, stimulates BDNF, and supports hippocampal volume [2][8]. These are not minor benefits at the margins, they address the core biological pathways through which depression damages the brain. If you can do one thing this week, go for a brisk 30-minute walk every day. That is not a platitude. It is, on the current evidence, a meaningful biological intervention.
4. Monitor dynamically, not just once. The research consistently shows that a single assessment of depression at one point in time misses important information [4][11][15]. What matters is the *trajectory*: are your symptoms increasing? Are you having more episodes over time? These dynamic patterns predict risk far better than any single snapshot.
5. Notice the early signs of cognitive change. Cognitive decline appears to *precede* depression in some people, and depression accelerates it thereafter [5]. If you notice increasing difficulty with concentration, planning, or mental flexibility, alongside a low mood, don’t assume it’s just stress or ageing. It’s worth discussing with a GP, particularly in the context of a personal or family history of depression.
6. The non-pharmacological interventions have the most consistent evidence. Aerobic exercise, cognitive engagement, social connection, and quality sleep are the interventions that appear across this research as protective. Antidepressants remain an important option, particularly for moderate to severe depression, but the evidence for their cognitive-protective benefits specifically is mixed and should be weighed carefully with professional guidance [3][6][10][12].
A sensible, informed person reading this evidence wouldn’t catastrophise. They’d recognise that depression is a modifiable risk factor, one of the few genuinely modifiable ones in the dementia picture, and they’d treat it with the same seriousness they’d give to blood pressure or cholesterol. Not because dementia is inevitable without intervention, but because the interventions are low-risk, the potential benefits are meaningful, and the cost of doing nothing is not zero.
Vitacuity read over 1.77 million research papers and selected the most relevant 15 studies on this topic. This is what the evidence actually says, not oversimplified, not alarming, but honest.
[1] Neurobiological and therapeutic landmarks of depression associated with Alzheimer’s disease dementia (2025). *Frontiers in Aging Neuroscience*. DOI: 10.3389/fnagi.2025.1584607 | https://pubmed.ncbi.nlm.nih.gov/40529210/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171374/
[2] Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise (2025). *Journal of Neurochemistry*. DOI: 10.1111/jnc.70185 | https://pubmed.ncbi.nlm.nih.gov/40757845/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320575/
[3] Antidepressant use in dementia: Assessing effective strategies for a vulnerable population (2025). *Neuroscience & Biobehavioral Reviews*. DOI: 10.1016/j.neubiorev.2025.106340 | https://pubmed.ncbi.nlm.nih.gov/40825453/
[4] Dynamic characteristics of depressive symptoms and risk of all-cause dementia and Alzheimer’s disease: Two population-based cohorts and evidence synthesis of longitudinal studies (2026). *Journal of Affective Disorders*. DOI: 10.1016/j.jad.2025.120646 | https://pubmed.ncbi.nlm.nih.gov/41224007/
[5] Cognitive decline before and after incident depression: Evidence from three international prospective cohorts (2026). *Archives of Gerontology and Geriatrics*. DOI: 10.1016/j.archger.2025.106086 | https://pubmed.ncbi.nlm.nih.gov/41275705/
[6] Exploring the Complex Relationship Between Antidepressants, Depression and Neurocognitive Disorders (2024). https://pubmed.ncbi.nlm.nih.gov/39767653/
[7] Neurobiological and therapeutic landmarks of depression associated with Alzheimer’s disease dementia (2025). *Frontiers in Aging Neuroscience*. DOI: 10.3389/fnagi.2025.1584607 | https://pubmed.ncbi.nlm.nih.gov/40529210/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12171374/
[8] Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical Exercise (2025). *Journal of Neurochemistry*. DOI: 10.1111/jnc.70185 | https://pubmed.ncbi.nlm.nih.gov/40757845/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12320575/
[9] Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors (2018). *Journal of Clinical Psychiatry*. DOI: 10.4088/JCP.18m12331 | https://pubmed.ncbi.nlm.nih.gov/30549490/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296258/
[10] Antidepressant use in dementia: Assessing effective strategies for a vulnerable population (2025). *Neuroscience & Biobehavioral Reviews*. DOI: 10.1016/j.neubiorev.2025.106340 | https://pubmed.ncbi.nlm.nih.gov/40825453/
[11] Sex-specific association of depressive symptom trajectories with cognitive decline and clinical progression in mild cognitive impairment (2025). *Alzheimer’s & Dementia*. DOI: 10.1002/alz.70548 | https://pubmed.ncbi.nlm.nih.gov/40754890/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12319156/
[12] Cognitive Deficits in Late-Life Depression: From Symptoms and Assessment to Therapeutics (2025). *Focus (American Psychiatric Association)*. DOI: 10.1176/appi.focus.20240046 | https://pubmed.ncbi.nlm.nih.gov/40235602/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11995896/
[13] Racial and ethnic differences in the association between depressive symptoms and cognitive outcomes in older adults: Findings from KHANDLE and STAR (2024). *Alzheimer’s & Dementia*. DOI: 10.1002/alz.13768 | https://pubmed.ncbi.nlm.nih.gov/38477489/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11095484/
[14] Does depression in mid-life predispose to greater cognitive decline in later life in the Whitehall II cohort? (2023). *Journal of Affective Disorders*. DOI: 10.1016/j.jad.2023.05.014 | https://pubmed.ncbi.nlm.nih.gov/37172658/
[15] Dynamic characteristics of depressive symptoms and risk of all-cause dementia and Alzheimer’s disease: Two population-based cohorts and evidence synthesis of longitudinal studies (2026). *Journal of Affective Disorders*. DOI: 10.1016/j.jad.2025.120646 | https://pubmed.ncbi.nlm.nih.gov/41224007/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read Vitamin D does more than support bones. It acts as a signalling molecule that switches genes on and
Quick Read Multiple large studies show that people who drink coffee regularly have lower rates of dementia and cognitive decline.
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.